Bascands J L, Girolami J P, Pecher C, Cabos G, Moatti J P, Suc J M, Manuel Y
Inserm U 133, Faculté de Médecine, Toulouse, France.
Agents Actions. 1987 Dec;22(3-4):302-9. doi: 10.1007/BF02009060.
Furosemide was administered for seven days to normal rats. Urinary kallikrein excretion showed a biphasic response during the seven consecutive days of study. During the initial three days only the kininogenase activity showed a significant increase without any variation in the excretion of the immunoreactive kallikrein. The specific urinary kininogenase activity was therefore enhanced. After three days of furosemide administration, both the urinary kininogenase activity and urinary immunoreactive kallikrein were augmented. The urinary specific kininogenase activity was that time no more different when compared to the basal value. Considering the delay time of three days, this second part of the response could be a mineralocorticoid mediated effect. In this respect, kidney level of immunoreactive and kininogenase activity of kallikrein are also increased after seven days of furosemide administration. However the short lasting increase in urinary specific kininogenase activity observed during the initial three days is due to a change in the ratio active versus inactive kallikrein without any variation of total kallikrein. It is possible that this immediate response results of a direct effect of furosemide acting either on the preferential excretion of the active form or on the activation of the prokallikrein in the urine.
将速尿给予正常大鼠七天。在连续七天的研究中,尿激肽释放酶排泄呈现双相反应。在最初三天,只有激肽原酶活性显著增加,而免疫反应性激肽释放酶的排泄没有任何变化。因此,尿特异性激肽原酶活性增强。给予速尿三天后,尿激肽原酶活性和尿免疫反应性激肽释放酶均增加。此时,尿特异性激肽原酶活性与基础值相比不再有差异。考虑到三天的延迟时间,这种反应的第二部分可能是盐皮质激素介导的效应。在这方面,给予速尿七天后,肾脏中激肽释放酶的免疫反应性和激肽原酶活性水平也会增加。然而,在最初三天观察到的尿特异性激肽原酶活性的短暂增加是由于活性与非活性激肽释放酶比例的变化,而总激肽释放酶没有任何变化。这种即时反应可能是速尿直接作用的结果,要么作用于活性形式的优先排泄,要么作用于尿液中激肽原酶原的激活。